These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9364302)

  • 1. Effect of suramin on differentiation of human stomach cancer cell lines.
    Choe G; Kim WH; Park JG; Kim YI
    J Korean Med Sci; 1997 Oct; 12(5):433-42. PubMed ID: 9364302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
    Kalli KR; Bradley SV; Fuchshuber S; Conover CA
    Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.
    Pommier GJ; Garrouste FL; el Atiq F; Roccabianca M; Marvaldi JL; Remacle-Bonnet MM
    Cancer Res; 1992 Jun; 52(11):3182-8. PubMed ID: 1375536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of suramin on squamous differentiation and apoptosis in three human non-small-cell lung cancer cell lines.
    Lokshin A; Levitt ML
    J Cell Biochem Suppl; 1996; 24():186-97. PubMed ID: 8806101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired carcinoembryonic antigen release during the process of suramin-induced differentiation of the human colonic adenocarcinoma cell clone HT29-D4.
    Fantini J; Rognoni JB; Theveniau M; Pommier G; Marvaldi J
    J Cell Physiol; 1990 Jun; 143(3):468-74. PubMed ID: 2162847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of growth stimulation by suramin in non-small-cell lung cancer cell lines.
    Lokshin A; Peng X; Campbell PG; Barsouk A; Levitt ML
    Cancer Chemother Pharmacol; 1999; 43(4):341-7. PubMed ID: 10071987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of suramin on cell-cycle kinetics of MCF-7 human breast cancer cells in vitro.
    Foekens JA; Sieuwerts AM; Stuurman-Smeets EM; Peters HA; Klijn JG
    Br J Cancer; 1993 Feb; 67(2):232-6. PubMed ID: 8431356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4.
    Fantini J; Rognoni JB; Roccabianca M; Pommier G; Marvaldi J
    J Biol Chem; 1989 Jun; 264(17):10282-6. PubMed ID: 2656707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of suramin on human lung cancer cell line in vitro].
    Fujiuchi S; Tsuji T; Ohsaki Y; Kikuchi K
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):647-52. PubMed ID: 8154891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suramin, an anti-cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A.
    Hensey CE; Boscoboinik D; Azzi A
    FEBS Lett; 1989 Nov; 258(1):156-8. PubMed ID: 2591531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suramin selectively inhibits carcinoma cell growth that is dependent on extracellular polyamines.
    Sandgren S; Belting M
    Anticancer Res; 2003; 23(2B):1223-8. PubMed ID: 12820375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposing effects of suramin and DL-alpha-difluoromethylornithine on polyamine metabolism contribute to a synergistic action on B16 melanoma cell growth in vitro.
    Gritli-Linde A; Björkman U; Delle U; Hultborn R; Johansson BR; Nannmark U; Linde A
    Anticancer Res; 1998; 18(2A):863-70. PubMed ID: 9615733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The enhancement of the chemotherapeutic effects on human prostate cancer cell--the combination with the growth factor interaction inhibitor (suramin)].
    Suzuki Y; Miwa Y; Akino H; Fujita T; Saikawa S; Kanimoto Y; Okada K
    Hinyokika Kiyo; 1993 Dec; 39(12):1215-20. PubMed ID: 8285172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term suramin treatment followed by the removal of the drug induces terminal differentiation of HT29-D4 cells.
    Baghdiguian S; Verrier B; Marvaldi J; Fantini J
    J Cell Physiol; 1992 Jan; 150(1):168-74. PubMed ID: 1730780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Suramin inhibits the proliferation and stimulates the differentiation of tumoral cell lines HT29-D4 and C6].
    Baghdiguian S; Pichon J; Marvaldi J; Fantini J
    Bull Cancer; 1991; 78(9):807-17. PubMed ID: 1751832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suramin-treated HT29-D4 cells grown in the presence of glucose in permeable culture chambers form electrically active epithelial monolayers. A comparative study with HT29-D4 cells grown in the absence of glucose.
    Fantini J; Rognoni JB; Verrier B; Lehmann M; Roccabianca M; Mauchamp J; Marvaldi J
    Eur J Cell Biol; 1990 Feb; 51(1):110-9. PubMed ID: 2328732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative effects of suramin on human cancer cells in vitro and in vivo.
    Bai L; Naomoto Y; Miyazaki M; Orita K; Namba M
    Acta Med Okayama; 1992 Dec; 46(6):457-63. PubMed ID: 1485540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suramin inhibits C6 glioma-induced angiogenesis in vitro.
    Coomber BL
    J Cell Biochem; 1995 Jun; 58(2):199-207. PubMed ID: 7545684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulatory effect of suramin on the proliferation of human glioma cells.
    Kuratsu J; Kurino M; Fukunaga K; Miyamoto E; Ushio Y
    Anticancer Res; 1995; 15(4):1263-8. PubMed ID: 7654006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of suramin on human esophageal cancer cells in vitro and in vivo.
    Shin R; Naomoto Y; Kamikawa Y; Tanaka N; Orita K
    Scand J Gastroenterol; 1997 Aug; 32(8):824-8. PubMed ID: 9282976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.